Hormonal therapy in the treatment of carcinoma of the prostate
- 1 April 1995
- Vol. 75 (S7), 1914-1919
- https://doi.org/10.1002/1097-0142(19950401)75:7+<1914::aid-cncr2820751626>3.0.co;2-q
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I TrialJNCI Journal of the National Cancer Institute, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Hormonal Therapy of Prostate Cancer: Limitations in the Total Androgen Ablation ConceptPublished by Springer Nature ,1988
- Treatment of patients with advanced cancer of the prostate: Phase III trial, zoladex against castration; a study of the British prostate groupJournal of Steroid Biochemistry, 1987
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic CarcinomaBMJ, 1971
- Isolation and properties of the FSH and LH-releasing hormoneBiochemical and Biophysical Research Communications, 1971
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941